Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Rang in aandelen #26082
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Aandeelprijs
$0.72978769
Marktkapitalisatie
$43.65M
Verandering (1 dag)
1.10%
Verandering (1 jaar)
-17.81%
Land
TW
Handel Bioptik Technology Incorporation (4161)

Categorie

Aandelsplitsingen voor Bioptik Technology Incorporation (4161)
Het aandeel Bioptik Technology Incorporation (symbool: 4161) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 20, 2026.
Eén aandeel 4161 dat vóór Aug 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 4161.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
0 -
DE